Apertura: | - |
Variazione: | - |
Volumi: | - |
Minimo: | - |
Massimi: | - |
Distanza Mas/Min: | - |
Tipologia: | Azioni |
Ticker: | CHWY |
ISIN: |
Chewy Announces Third Quarter 2024 Financial Results
- 97
Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the third quarter of fiscal year 2024 ended October 27, 2024.
Fiscal Q3 2024 Highlights:
- Net sales of $2.88 billion increased 4.8 percent year over year
- Gross margin of 29.3 percent increased 80 basis points year over year
- Net income of $3.9 million, including share-based compensation expense and related taxes of $80.4 million
- Net margin of 0.1 percent increased 140 basis points year over year
- Basic and diluted earnings per share of $0.01, an increase of $0.09 year over year
- Adjusted EBITDA(1) of $138.2 million, an increase of $55.7 million year over year
- Adjusted EBITDA margin(1) of 4.8 percent increased 180 basis points year over year
- Adjusted net income(1) of $84.9 million, an increase of $21.5 million year over year
- Adjusted basic and diluted earnings per share(1) of $0.20, an increase of $0.05 year over year
“Our third quarter results continued to build on the positive momentum we observed in Q2,” said Sumit Singh, Chief Executive Officer of Chewy. “We delivered topline growth exceeding the high-end of our net sales guidance range, a sequential increase in active customers, continued adjusted EBITDA margin expansion, and robust free cash flow generation. These results underscore the durability of our business model, and our team’s relentless focus on high-quality execution and operational discipline.”
Management will host a conference call and webcast to discuss Chewy's financial results today at 8:00 am ET.
Chewy Fiscal Third Quarter 2024 Financial Results Conference Call
When: Wednesday, December 4, 2024
Time: 8:00 am ET
Live webcast and replay: https://investor.chewy.com
Conference call registration: https://www.netroadshow.com/events/login?show=4d7c8222&confId=72627
(1) |
Adjusted EBITDA, adjusted EBITDA margin, adjusted net income, and adjusted basic and diluted earnings per share are non-GAAP financial measures. See “Non-GAAP Financial Measures” for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures. |
About Chewy
Our mission is to be the most trusted and convenient destination for pet parents and partners everywhere. We believe that we are the preeminent online source for pet products, supplies, and prescriptions as a result of our broad selection of high-quality products and services, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch to build brand loyalty and drive repeat purchasing. We seek to continually develop innovative ways for our customers to engage with us, as our websites and mobile applications allow our pet parents to manage their pets’ health, wellness, and merchandise needs, while enabling them to conveniently shop for our products. We partner with approximately 3,500 of the best and most trusted brands in the pet industry, and we create and offer our own private brands. Through our websites and mobile applications, we offer our customers approximately 115,000 products and services offerings, to bring what we believe is a high-bar, customer-centric experience to our customers.
Forward-Looking Statements
This communication contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this communication, including statements regarding our share repurchase program, our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements.
In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will” or “would” or the negative of these words or other similar terms or expressions. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could cause actual results to differ materially from those in such forward-looking statements, including but not limited to, our ability to: sustain our recent growth rates and successfully manage challenges to our future growth, including introducing new products or services, improving existing products and services, and expanding into new jurisdictions and offerings; successfully respond to business disruptions; successfully manage risks related to the macroeconomic environment, including any adverse impacts on our business operations, financial performance, supply chain, workforce, facilities, customer services and operations; acquire and retain new customers in a cost-effective manner and increase our net sales, improve margins and maintain profitability; manage our growth effectively; maintain positive perceptions of the Company and preserve, grow, and leverage the value of our reputation and our brand; limit operating losses as we continue to expand our business; forecast net sales and appropriately plan our expenses in the future; estimating our market share; strengthen our current supplier relationships, retain key suppliers, and source additional suppliers; negotiate acceptable pricing and other terms with third-party service providers, suppliers and outsourcing partners and maintain our relationships with such parties; mitigate changes in, or disruptions to, our shipping arrangements and operations; optimize, operate and manage the expansion of the capacity of our fulfillment centers; provide our customers with a cost-effective platform that is able to respond and adapt to rapid changes in technology; limit our losses related to online payment methods; maintain and scale our technology, including the reliability of our websites, mobile applications, and network infrastructure; maintain adequate cybersecurity with respect to our systems and retain third-party service providers that do the same with respect to their systems; maintain consumer confidence in the safety, quality and health of our products; limit risks associated with our suppliers and our outsourcing partners; comply with existing or future laws and regulations in a cost-efficient manner; utilize net operating loss and tax credit carryforwards, and other tax attributes; adequately protect our intellectual property rights; successfully defend ourselves against any allegations or claims that we may be subject to; attract, develop, motivate and retain highly-qualified and skilled employees; respond to economic conditions, industry trends, and market conditions, and their impact on the pet products market; reduce merchandise returns or refunds; respond to severe weather and limit disruption to normal business operations; manage new acquisitions, investments or alliances, and integrate them into our existing business; successfully compete in new offerings; manage challenges presented by international markets; successfully compete in the pet products and services health and retail industry, especially in the e-commerce sector; comply with the terms of our credit facility; raise capital as needed; and maintain effective internal control over financial reporting.
You should not rely on forward-looking statements as predictions of future events, and you should understand that these statements are not guarantees of performance or results, and our actual results could differ materially from those expressed in the forward-looking statements due to a variety of factors. We have based the forward-looking statements contained in this communication primarily on our current assumptions, expectations, and projections about future events and trends that we believe may affect our business, financial condition, and results of operations. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled “Risk Factors” in our Quarterly Report on Form 10-Q for the quarterly period ended April 28, 2024, in our other filings with the Securities and Exchange Commission, and elsewhere in this communication. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this communication. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this communication. While we believe that such information provides a reasonable basis for these statements, this information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this communication to reflect events or circumstances after the date of this communication or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.
CHEWY, INC. |
|||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
(in thousands, except share and per share data) |
|||||||
|
As of |
||||||
|
October 27,
|
|
January 28,
|
||||
Assets |
(Unaudited) |
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
506,634 |
|
|
$ |
602,232 |
|
Marketable securities |
|
885 |
|
|
|
531,785 |
|
Accounts receivable |
|
193,210 |
|
|
|
154,043 |
|
Inventories |
|
858,551 |
|
|
|
719,273 |
|
Prepaid expenses and other current assets |
|
56,445 |
|
|
|
97,015 |
|
Total current assets |
|
1,615,725 |
|
|
|
2,104,348 |
|
Property and equipment, net |
|
527,738 |
|
|
|
521,298 |
|
Operating lease right-of-use assets |
|
458,037 |
|
|
|
474,617 |
|
Goodwill |
|
39,442 |
|
|
|
39,442 |
|
Deferred tax assets |
|
275,669 |
|
|
|
— |
|
Other non-current assets |
|
41,286 |
|
|
|
47,146 |
|
Total assets |
$ |
2,957,897 |
|
|
$ |
3,186,851 |
|
Liabilities and stockholders’ equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Trade accounts payable |
$ |
1,229,132 |
|
|
$ |
1,104,940 |
|
Accrued expenses and other current liabilities |
|
950,093 |
|
|
|
1,005,937 |
|
Total current liabilities |
|
2,179,225 |
|
|
|
2,110,877 |
|
Operating lease liabilities |
|
510,612 |
|
|
|
527,795 |
|
Other long-term liabilities |
|
44,638 |
|
|
|
37,935 |
|
Total liabilities |
|
2,734,475 |
|
|
|
2,676,607 |
|
Stockholders’ equity: |
|
|
|
||||
Preferred stock, $0.01 par value per share, 5,000,000 shares authorized, no shares issued and outstanding as of October 27, 2024 and January 28, 2024 |
|
— |
|
|
|
— |
|
Class A common stock, $0.01 par value per share, 1,500,000,000 shares authorized, 161,522,237 and 132,913,046 shares issued and outstanding as of October 27, 2024 and January 28, 2024, respectively |
|
1,615 |
|
|
|
1,329 |
|
Class B common stock, $0.01 par value per share, 395,000,000 shares authorized, 246,525,803 and 298,863,356 shares issued and outstanding as of October 27, 2024 and January 28, 2024, respectively |
|
2,465 |
|
|
|
2,989 |
|
Additional paid-in capital |
|
1,824,384 |
|
|
|
2,481,984 |
|
Accumulated deficit |
|
(1,605,706 |
) |
|
|
(1,975,652 |
) |
Accumulated other comprehensive income (loss) |
|
664 |
|
|
|
(406 |
) |
Total stockholders’ equity |
|
223,422 |
|
|
|
510,244 |
|
Total liabilities and stockholders’ equity |
$ |
2,957,897 |
|
|
$ |
3,186,851 |
|
CHEWY, INC. |
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) |
|||||||||||||||
(in thousands, except per share data) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
|
October 27,
|
|
October 29,
|
|
October 27,
|
|
October 29,
|
||||||||
Net sales |
$ |
2,877,635 |
|
|
$ |
2,745,875 |
|
|
$ |
8,613,949 |
|
|
$ |
8,321,816 |
|
Cost of goods sold |
|
2,033,762 |
|
|
|
1,964,019 |
|
|
|
6,072,248 |
|
|
|
5,958,383 |
|
Gross profit |
|
843,873 |
|
|
|
781,856 |
|
|
|
2,541,701 |
|
|
|
2,363,433 |
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative |
|
626,471 |
|
|
|
612,375 |
|
|
|
1,850,299 |
|
|
|
1,816,653 |
|
Advertising and marketing |
|
191,770 |
|
|
|
179,200 |
|
|
|
569,103 |
|
|
|
548,424 |
|
Total operating expenses |
|
818,241 |
|
|
|
791,575 |
|
|
|
2,419,402 |
|
|
|
2,365,077 |
|
Income (loss) from operations |
|
25,632 |
|
|
|
(9,719 |
) |
|
|
122,299 |
|
|
|
(1,644 |
) |
Interest income, net |
|
3,901 |
|
|
|
10,173 |
|
|
|
31,345 |
|
|
|
27,117 |
|
Other (expense) income, net |
|
(36 |
) |
|
|
(34,122 |
) |
|
|
746 |
|
|
|
(13,768 |
) |
Income (loss) before income tax provision (benefit) |
|
29,497 |
|
|
|
(33,668 |
) |
|
|
154,390 |
|
|
|
11,705 |
|
Income tax provision (benefit) |
|
25,565 |
|
|
|
1,704 |
|
|
|
(215,556 |
) |
|
|
4,011 |
|
Net income (loss) |
$ |
3,932 |
|
|
$ |
(35,372 |
) |
|
$ |
369,946 |
|
|
$ |
7,694 |
|
|
|
|
|
|
|
|
|
||||||||
Comprehensive income (loss): |
|
|
|
|
|
|
|
||||||||
Net income (loss) |
$ |
3,932 |
|
|
$ |
(35,372 |
) |
|
$ |
369,946 |
|
|
$ |
7,694 |
|
Foreign currency translation adjustments |
|
317 |
|
|
|
— |
|
|
|
1,070 |
|
|
|
— |
|
Comprehensive income (loss) |
$ |
4,249 |
|
|
$ |
(35,372 |
) |
|
$ |
371,016 |
|
|
$ |
7,694 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share attributable to common Class A and Class B stockholders: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.01 |
|
|
$ |
(0.08 |
) |
|
$ |
0.87 |
|
|
$ |
0.02 |
|
Diluted |
$ |
0.01 |
|
|
$ |
(0.08 |
) |
|
$ |
0.85 |
|
|
$ |
0.02 |
|
Weighted-average common shares used in computing earnings (loss) per share: |
|
|
|
|
|
|
|
||||||||
Basic |
|
414,361 |
|
|
|
430,758 |
|
|
|
426,203 |
|
|
|
428,743 |
|
Diluted |
|
426,572 |
|
|
|
430,758 |
|
|
|
433,625 |
|
|
|
431,406 |
|
CHEWY, INC. |
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(in thousands) |
|||||||
(Unaudited) |
|||||||
|
39 Weeks Ended |
||||||
|
October 27,
|
|
October 29,
|
||||
Cash flows from operating activities |
|
|
|
||||
Net income |
$ |
369,946 |
|
|
$ |
7,694 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
85,436 |
|
|
|
82,252 |
|
Share-based compensation expense |
|
224,710 |
|
|
|
178,897 |
|
Non-cash lease expense |
|
24,529 |
|
|
|
29,399 |
|
Change in fair value of equity warrants and investments |
|
875 |
|
|
|
13,589 |
|
Deferred income tax benefit |
|
(275,669 |
) |
|
|
— |
|
Unrealized foreign currency losses, net |
|
1,218 |
|
|
|
— |
|
Other |
|
(141 |
) |
|
|
3,810 |
|
Net change in operating assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
(39,208 |
) |
|
|
(34,436 |
) |
Inventories |
|
(139,454 |
) |
|
|
(36,846 |
) |
Prepaid expenses and other current assets |
|
(9,892 |
) |
|
|
(27,346 |
) |
Other non-current assets |
|
2,803 |
|
|
|
(1,337 |
) |
Trade accounts payable |
|
124,238 |
|
|
|
48,755 |
|
Accrued expenses and other current liabilities |
|
40,440 |
|
|
|
140,374 |
|
Operating lease liabilities |
|
(23,088 |
) |
|
|
(19,805 |
) |
Other long-term liabilities |
|
2,066 |
|
|
|
1,664 |
|
Net cash provided by operating activities |
|
388,809 |
|
|
|
386,664 |
|
Cash flows from investing activities |
|
|
|
||||
Capital expenditures |
|
(92,920 |
) |
|
|
(110,902 |
) |
Proceeds from sales and maturities of marketable securities |
|
538,402 |
|
|
|
750,000 |
|
Purchases of marketable securities |
|
— |
|
|
|
(876,189 |
) |
Cash paid for acquisition of business, net of cash acquired |
|
— |
|
|
|
(367 |
) |
Net cash provided by (used in) investing activities |
|
445,482 |
|
|
|
(237,458 |
) |
Cash flows from financing activities |
|
|
|
||||
Repurchases of common stock |
|
(875,197 |
) |
|
|
— |
|
Income taxes paid for, net of proceeds from, parent reorganization transaction |
|
(53,743 |
) |
|
|
— |
|
Principal repayments of finance lease obligations |
|
(730 |
) |
|
|
(479 |
) |
Payments of secondary offering costs |
|
(58 |
) |
|
|
— |
|
Payments for tax withholdings related to vesting of share-based compensation awards |
|
(13 |
) |
|
|
(5 |
) |
Payments for tax sharing agreement with related parties |
|
— |
|
|
|
(10,279 |
) |
Payment of debt modification costs |
|
— |
|
|
|
(175 |
) |
Net cash used in financing activities |
|
(929,741 |
) |
|
|
(10,938 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(148 |
) |
|
|
— |
|
Net (decrease) increase in cash and cash equivalents |
|
(95,598 |
) |
|
|
138,268 |
|
Cash and cash equivalents, as of beginning of period |
|
602,232 |
|
|
|
331,641 |
|
Cash and cash equivalents, as of end of period |
$ |
506,634 |
|
|
$ |
469,909 |
|
Key Financial and Operating Data
We measure our business using both financial and operating data and use the following metrics and measures to assess the near-term and long-term performance of our overall business, including identifying trends, formulating financial projections, making strategic decisions, assessing operational efficiencies, and monitoring our business.
|
13 Weeks Ended |
|
|
|
39 Weeks Ended |
|
|
||||||||||||||
(in thousands, except net sales per active customer, per share data, and percentages) |
October 27,
|
|
October 29,
|
|
%
|
|
October 27,
|
|
October 29,
|
|
%
|
||||||||||
Financial and Operating Data |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales |
$ |
2,877,635 |
|
|
$ |
2,745,875 |
|
|
4.8 |
% |
|
$ |
8,613,949 |
|
|
$ |
8,321,816 |
|
|
3.5 |
% |
Net income (loss) (1) |
$ |
3,932 |
|
|
$ |
(35,372 |
) |
|
111.1 |
% |
|
$ |
369,946 |
|
|
$ |
7,694 |
|
|
n/m |
|
Net margin |
|
0.1 |
% |
|
|
(1.3 |
)% |
|
|
|
|
4.3 |
% |
|
|
0.1 |
% |
|
|
||
Adjusted EBITDA (2) |
$ |
138,245 |
|
|
$ |
82,581 |
|
|
67.4 |
% |
|
$ |
446,004 |
|
|
$ |
281,601 |
|
|
58.4 |
% |
Adjusted EBITDA margin (2) |
|
4.8 |
% |
|
|
3.0 |
% |
|
|
|
|
5.2 |
% |
|
|
3.4 |
% |
|
|
||
Adjusted net income (2) |
$ |
84,922 |
|
|
$ |
63,449 |
|
|
33.8 |
% |
|
$ |
326,776 |
|
|
$ |
215,953 |
|
|
51.3 |
% |
Earnings (loss) per share, basic (1) |
$ |
0.01 |
|
|
$ |
(0.08 |
) |
|
112.5 |
% |
|
$ |
0.87 |
|
|
$ |
0.02 |
|
|
n/m |
|
Earnings (loss) per share, diluted (1) |
$ |
0.01 |
|
|
$ |
(0.08 |
) |
|
112.5 |
% |
|
$ |
0.85 |
|
|
$ |
0.02 |
|
|
n/m |
|
Adjusted earnings per share, basic (2) |
$ |
0.20 |
|
|
$ |
0.15 |
|
|
33.3 |
% |
|
$ |
0.77 |
|
|
$ |
0.50 |
|
|
54.0 |
% |
Adjusted earnings per share, diluted (2) |
$ |
0.20 |
|
|
$ |
0.15 |
|
|
33.3 |
% |
|
$ |
0.75 |
|
|
$ |
0.50 |
|
|
50.0 |
% |
Net cash provided by operating activities |
$ |
183,462 |
|
|
$ |
79,377 |
|
|
131.1 |
% |
|
$ |
388,809 |
|
|
$ |
386,664 |
|
|
0.6 |
% |
Free cash flow (2) |
$ |
151,767 |
|
|
$ |
47,692 |
|
|
218.2 |
% |
|
$ |
295,889 |
|
|
$ |
275,762 |
|
|
7.3 |
% |
Active customers |
|
20,160 |
|
|
|
20,266 |
|
|
(0.5 |
)% |
|
|
20,160 |
|
|
|
20,266 |
|
|
(0.5 |
)% |
Net sales per active customer |
$ |
567 |
|
|
$ |
544 |
|
|
4.2 |
% |
|
$ |
567 |
|
|
$ |
544 |
|
|
4.2 |
% |
Autoship customer sales |
$ |
2,300,928 |
|
|
$ |
2,116,458 |
|
|
8.7 |
% |
|
$ |
6,775,983 |
|
|
$ |
6,334,240 |
|
|
7.0 |
% |
Autoship customer sales as a percentage of net sales |
|
80.0 |
% |
|
|
77.1 |
% |
|
|
|
|
78.7 |
% |
|
|
76.1 |
% |
|
|
||
n/m - not meaningful |
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes share-based compensation expense and related taxes of $80.4 million and $232.4 million for the thirteen and thirty-nine weeks ended October 27, 2024, compared to $65.8 million and $187.9 million for the thirteen and thirty-nine weeks ended October 29, 2023. |
(2) |
Adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted basic and diluted earnings per share, and free cash flow are non-GAAP financial measures. |
We define net margin as net income divided by net sales and adjusted EBITDA margin as adjusted EBITDA divided by net sales.
Non-GAAP Financial Measures
Adjusted EBITDA and Adjusted EBITDA Margin
To provide investors with additional information regarding our financial results, we have disclosed in this earnings release adjusted EBITDA, a non-GAAP financial measure that we calculate as net income excluding depreciation and amortization; share-based compensation expense and related taxes; income tax provision (benefit); interest income (expense), net; transaction related costs; changes in the fair value of equity warrants; severance and exit costs; and litigation matters and other items that we do not consider representative of our underlying operations. We have provided a reconciliation below of adjusted EBITDA to net income, the most directly comparable GAAP financial measure.
We have included adjusted EBITDA and adjusted EBITDA margin in this earnings release because each is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted EBITDA and adjusted EBITDA margin facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and certain variable charges. Accordingly, we believe that adjusted EBITDA and adjusted EBITDA margin provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.
We believe it is useful to exclude non-cash charges, such as depreciation and amortization and share-based compensation expense from our adjusted EBITDA because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude income tax provision (benefit); interest income (expense), net; transaction related costs; changes in the fair value of equity warrants; and litigation matters and other items which are not components of our core business operations. We believe it is useful to exclude severance and exit costs because these expenses represent temporary initiatives to realign resources and enhance operational efficiency, which are not components of our core business operations. Adjusted EBITDA has limitations as a financial measure and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future and adjusted EBITDA does not reflect capital expenditure requirements for such replacements or for new capital expenditures;
- adjusted EBITDA does not reflect share-based compensation and related taxes. Share-based compensation has been, and will continue to be for the foreseeable future, a recurring expense in our business and an important part of our compensation strategy;
- adjusted EBITDA does not reflect interest income (expense), net; or changes in, or cash requirements for, our working capital;
- adjusted EBITDA does not reflect transaction related costs and other items which are either not representative of our underlying operations or are incremental costs that result from an actual or planned transaction or initiative and include changes in the fair value of equity warrants, severance and exit costs, litigation matters, integration consulting fees, internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities) and certain costs related to integrating and converging IT systems; and
- other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
Because of these limitations, you should consider adjusted EBITDA and adjusted EBITDA margin alongside other financial performance measures, including various cash flow metrics, net income, net margin, and our other GAAP results.
The following table presents a reconciliation of net income (loss) to adjusted EBITDA, as well as the calculation of net margin and adjusted EBITDA margin, for each of the periods indicated:
(in thousands, except percentages) |
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
Reconciliation of Net Income (Loss) to Adjusted EBITDA |
October 27,
|
|
October 29,
|
|
October 27,
|
|
October 29,
|
||||||||
Net income (loss) |
$ |
3,932 |
|
|
$ |
(35,372 |
) |
|
$ |
369,946 |
|
|
$ |
7,694 |
|
Add (deduct): |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
28,981 |
|
|
|
25,540 |
|
|
|
85,436 |
|
|
|
82,252 |
|
Share-based compensation expense and related taxes |
|
80,426 |
|
|
|
65,799 |
|
|
|
232,377 |
|
|
|
187,878 |
|
Interest income, net |
|
(3,901 |
) |
|
|
(10,173 |
) |
|
|
(31,345 |
) |
|
|
(27,117 |
) |
Change in fair value of equity warrants |
|
564 |
|
|
|
33,800 |
|
|
|
122 |
|
|
|
13,542 |
|
Income tax provision (benefit) |
|
25,565 |
|
|
|
1,704 |
|
|
|
(215,556 |
) |
|
|
4,011 |
|
Exit costs |
|
— |
|
|
|
(778 |
) |
|
|
— |
|
|
|
6,839 |
|
Transaction related costs |
|
457 |
|
|
|
1,041 |
|
|
|
928 |
|
|
|
3,167 |
|
Other |
|
2,221 |
|
|
|
1,020 |
|
|
|
4,096 |
|
|
|
3,335 |
|
Adjusted EBITDA |
$ |
138,245 |
|
|
$ |
82,581 |
|
|
$ |
446,004 |
|
|
$ |
281,601 |
|
Net sales |
$ |
2,877,635 |
|
|
$ |
2,745,875 |
|
|
$ |
8,613,949 |
|
|
$ |
8,321,816 |
|
Net margin |
|
0.1 |
% |
|
|
(1.3 |
)% |
|
|
4.3 |
% |
|
|
0.1 |
% |
Adjusted EBITDA margin |
|
4.8 |
% |
|
|
3.0 |
% |
|
|
5.2 |
% |
|
|
3.4 |
% |
Adjusted Net Income and Adjusted Basic and Diluted Earnings per Share
To provide investors with additional information regarding our financial results, we have disclosed in this earnings release adjusted net income and adjusted basic and diluted earnings per share, which represent non-GAAP financial measures. We calculate adjusted net income as net income excluding share-based compensation expense and related taxes, changes in valuation allowances associated with deferred tax assets, changes in the fair value of equity warrants, and severance and exit costs. We calculate adjusted basic and diluted earnings per share by dividing adjusted net income attributable to common stockholders by the weighted-average shares outstanding during the period. We have provided a reconciliation below of adjusted net income to net income , the most directly comparable GAAP financial measure.
We have included adjusted net income and adjusted basic and diluted earnings per share in this earnings release because each is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted net income and adjusted basic and diluted earnings per share facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and certain variable gains and losses that do not represent a component of our core business operations. We believe it is useful to exclude non-cash share-based compensation expense because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude changes in valuation allowances associated with deferred tax assets as this is not a component of our core business operations. We believe it is useful to exclude changes in the fair value of equity warrants because the variability of equity warrant gains and losses is not representative of our underlying operations. We believe it is useful to exclude severance and exit costs because these expenses represent temporary initiatives to realign resources and enhance operational efficiency, which are not components of our core business operations. Accordingly, we believe that these measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.
Adjusted net income and adjusted basic and diluted earnings per share have limitations as financial measures and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. Other companies may calculate adjusted net income and adjusted basic and diluted earnings per share differently, which reduces their usefulness as comparative measures. Because of these limitations, you should consider adjusted net income and adjusted basic and diluted earnings alongside other financial performance measures, including various cash flow metrics, net income, basic and diluted earnings per share, and our other GAAP results.
The following table presents a reconciliation of net income (loss) to adjusted net income, as well as the calculation of adjusted basic and diluted earnings (loss) per share, for each of the periods indicated:
(in thousands, except per share data) |
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||
Reconciliation of Net Income (Loss) to Adjusted Net Income |
October 27,
|
|
October 29,
|
|
October 27,
|
|
October 29,
|
||||||
Net income (loss) |
$ |
3,932 |
|
$ |
(35,372 |
) |
|
$ |
369,946 |
|
|
$ |
7,694 |
Add (deduct): |
|
|
|
|
|
|
|
||||||
Share-based compensation expense and related taxes |
|
80,426 |
|
|
65,799 |
|
|
|
232,377 |
|
|
|
187,878 |
Change in fair value of equity warrants |
|
564 |
|
|
33,800 |
|
|
|
122 |
|
|
|
13,542 |
Deferred income tax benefit |
|
— |
|
|
— |
|
|
|
(275,669 |
) |
|
|
— |
Exit costs |
|
— |
|
|
(778 |
) |
|
|
— |
|
|
|
6,839 |
Adjusted net income |
$ |
84,922 |
|
$ |
63,449 |
|
|
$ |
326,776 |
|
|
$ |
215,953 |
Weighted-average common shares used in computing earnings (loss) per share and adjusted earnings per share: |
|
|
|
|
|
|
|
||||||
Basic |
|
414,361 |
|
|
430,758 |
|
|
|
426,203 |
|
|
|
428,743 |
Effect of dilutive share-based awards (1) |
|
12,211 |
|
|
1,414 |
|
|
|
7,422 |
|
|
|
2,663 |
Diluted (1) |
|
426,572 |
|
|
432,172 |
|
|
|
433,625 |
|
|
|
431,406 |
Earnings (loss) per share attributable to common Class A and Class B stockholders |
|
|
|
|
|
|
|
||||||
Basic |
$ |
0.01 |
|
$ |
(0.08 |
) |
|
$ |
0.87 |
|
|
$ |
0.02 |
Diluted (1) |
$ |
0.01 |
|
$ |
(0.08 |
) |
|
$ |
0.85 |
|
|
$ |
0.02 |
Adjusted basic |
$ |
0.20 |
|
$ |
0.15 |
|
|
$ |
0.77 |
|
|
$ |
0.50 |
Adjusted diluted (1) |
$ |
0.20 |
|
$ |
0.15 |
|
|
$ |
0.75 |
|
|
$ |
0.50 |
(1) |
For the thirteen weeks ended October 29, 2023, our calculation of adjusted diluted earnings per share attributable to common Class A and Class B stockholders requires an adjustment to the weighted-average common shares used in the calculation to include the weighted-average dilutive effect of share-based awards. |
Free Cash Flow
To provide investors with additional information regarding our financial results, we also disclose free cash flow, a non-GAAP financial measure that we calculate as net cash provided by (used in) operating activities less capital expenditures (which consist of purchases of property and equipment, capitalization of labor related to our websites, mobile applications, software development, and leasehold improvements). We have provided a reconciliation below of free cash flow to net cash provided by (used in) operating activities, the most directly comparable GAAP financial measure.
We have included free cash flow because it is used by our management and board of directors as an important indicator of our liquidity as it measures the amount of cash we generate. Accordingly, we believe that free cash flow provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.
Free cash flow has limitations as a financial measure and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. There are limitations to using non-GAAP financial measures, including that other companies, including companies in our industry, may calculate free cash flow differently. Because of these limitations, you should consider free cash flow alongside other financial performance measures, including net cash provided by (used in) operating activities, capital expenditures and our other GAAP results.
The following table presents a reconciliation of net cash provided by operating activities to free cash flow for each of the periods indicated:
(in thousands) |
13 Weeks Ended |
|
39 Weeks Ended |
||||||||||||
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow |
October 27,
|
|
October 29,
|
|
October 27,
|
|
October 29,
|
||||||||
Net cash provided by operating activities |
$ |
183,462 |
|
|
$ |
79,377 |
|
|
$ |
388,809 |
|
|
$ |
386,664 |
|
Deduct: |
|
|
|
|
|
|
|
||||||||
Capital expenditures |
|
(31,695 |
) |
|
|
(31,685 |
) |
|
|
(92,920 |
) |
|
|
(110,902 |
) |
Free Cash Flow |
$ |
151,767 |
|
|
$ |
47,692 |
|
|
$ |
295,889 |
|
|
$ |
275,762 |
|
Free cash flow may be affected in the near to medium term by the timing of capital investments (such as the launch of new fulfillment centers, pharmacy facilities, veterinary clinics, customer service infrastructure, and corporate offices and purchases of IT and other equipment), fluctuations in our growth and the effect of such fluctuations on working capital, and changes in our cash conversion cycle due to increases or decreases of vendor payment terms as well as inventory turnover.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241204895541/en/